表紙
市場調査レポート

フェニルケトン尿症:世界の治験レビュー

Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 304748
出版日 ページ情報 英文 101 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
フェニルケトン尿症:世界の治験レビュー Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2014
出版日: 2014年05月26日 ページ情報: 英文 101 Pages
概要

当レポートでは、フェニルケトン尿症に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • フェニルケトン尿症
  • 当レポートの概要

各地域における治験状況

各国の治験件数と平均被験者数

  • 欧州の主要5ヶ国における治験件数
  • 北米の主要国における治験件数
  • 中東およびアフリカの主要国における治験件数

G7諸国における治験件数:代謝性疾患の治験件数に対するフェニルケトン尿症の比率

G7諸国における治験件数:フェーズ(相)別

G7諸国における治験件数:進捗状況別

E7(新興7カ国)における治験件数:代謝性疾患の治験件数に対するフェニルケトン尿症の比率

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • BioMarin Pharmaceutical Inc.
    • E. Merck KG
  • 代表的な研究機関・病院の治験の概要
    • Emory University
    • University of Leipzig
    • Washington University School of Medicine
    • University of Miami
    • University of Southern California
    • Ludwig-Maximilians-Universitat Munich
    • The University of Texas Health Science Center at Houston
    • Hamilton Health Sciences
    • University Hospital, Tours
    • University of Missouri

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2169CTIDB

GlobalData's clinical trial report, "Phenylketonuria (PKU) Global Clinical Trials Review, H1, 2014" provides data on the Phenylketonuria (PKU) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Phenylketonuria (PKU). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Phenylketonuria (PKU). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Phenylketonuria (PKU)
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Phenylketonuria (PKU)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Phenylketonuria (PKU) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • BioMarin Pharmaceutical Inc.
      • Clinical Trial Overview of BioMarin Pharmaceutical Inc.
      • E. Merck KG
      • Clinical Trial Overview of E. Merck KG
    • Clinical Trial Overview of Top Institutes / Government
      • Emory University
      • Clinical Trial Overview of Emory University
      • University of Leipzig
      • Clinical Trial Overview of University of Leipzig
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • University of Miami
      • Clinical Trial Overview of University of Miami
      • University of Southern California
      • Clinical Trial Overview of University of Southern California
      • Ludwig-Maximilians-Universitat Munich
      • Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich
      • The University of Texas Health Science Center at Houston
      • Clinical Trial Overview of The University of Texas Health Science Center at Houston
      • Hamilton Health Sciences
      • Clinical Trial Overview of Hamilton Health Sciences
      • University Hospital, Tours
      • Clinical Trial Overview of University Hospital, Tours
      • University of Missouri
      • Clinical Trial Overview of University of Missouri
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Phenylketonuria (PKU) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Phenylketonuria (PKU) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Phenylketonuria (PKU) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by BioMarin Pharmaceutical Inc., 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas Health Science Center at Houston, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamilton Health Sciences, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2014*

List of Figures

  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Phenylketonuria (PKU) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Phenylketonuria (PKU) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Phenylketonuria (PKU) to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Phenylketonuria (PKU) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Phenylketonuria (PKU) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Phenylketonuria (PKU) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top